Εμφάνιση απλής εγγραφής

dc.creatorSciagrà R., Lubberink M., Hyafil F., Saraste A., Slart R.H.J.A., Agostini D., Nappi C., Georgoulias P., Bucerius J., Rischpler C., Verberne H.J., Cardiovascular Committee of the European Association of Nuclear Medicine (EANM)en
dc.date.accessioned2023-01-31T09:54:46Z
dc.date.available2023-01-31T09:54:46Z
dc.date.issued2021
dc.identifier10.1007/s00259-020-05046-9
dc.identifier.issn16197070
dc.identifier.urihttp://hdl.handle.net/11615/78865
dc.description.abstractThe use of cardiac PET, and in particular of quantitative myocardial perfusion PET, has been growing during the last years, because scanners are becoming widely available and because several studies have convincingly demonstrated the advantages of this imaging approach. Therefore, there is a need of determining the procedural modalities for performing high-quality studies and obtaining from this demanding technique the most in terms of both measurement reliability and clinical data. Although the field is rapidly evolving, with progresses in hardware and software, and the near perspective of new tracers, the EANM Cardiovascular Committee found it reasonable and useful to expose in an updated text the state of the art of quantitative myocardial perfusion PET, in order to establish an effective use of this modality and to help implementing it on a wider basis. Together with the many steps necessary for the correct execution of quantitative measurements, the importance of a multiparametric approach and of a comprehensive and clinically useful report have been stressed. © 2020, The Author(s).en
dc.language.isoenen
dc.sourceEuropean Journal of Nuclear Medicine and Molecular Imagingen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85094868473&doi=10.1007%2fs00259-020-05046-9&partnerID=40&md5=2f59abd8ae02ff9a5c4f385c17b13a2b
dc.subjectdipyridamoleen
dc.subjectfluorodeoxyglucose f 18en
dc.subjectflurpiridaz f 18en
dc.subjectnitrogen 13en
dc.subjectregadenosonen
dc.subjectrubidium 82en
dc.subjectwater o 15en
dc.subjectradioisotopeen
dc.subjectarterial blooden
dc.subjectArticleen
dc.subjectblood volumeen
dc.subjectcardiac muscleen
dc.subjectclinical protocolen
dc.subjectcomparative studyen
dc.subjectcoronary artery blood flowen
dc.subjectcoronary artery diseaseen
dc.subjectcoronary flow reserveen
dc.subjectdiagnostic accuracyen
dc.subjectdynamic exerciseen
dc.subjectgated imagingen
dc.subjectheart ejection fractionen
dc.subjectheart muscle blood flowen
dc.subjectheart muscle ischemiaen
dc.subjectheart muscle perfusionen
dc.subjectheart perfusionen
dc.subjecthumanen
dc.subjectimage qualityen
dc.subjectimage reconstructionen
dc.subjectlimit of quantitationen
dc.subjectlow risk populationen
dc.subjectmedical societyen
dc.subjectmyocardial perfusion imagingen
dc.subjectpositron emission tomography-computed tomographyen
dc.subjectpractice guidelineen
dc.subjectpredictive valueen
dc.subjectprognosisen
dc.subjectquantitative studyen
dc.subjectradiation exposureen
dc.subjectreconstruction algorithmen
dc.subjectrespiratory gated imagingen
dc.subjectsensitivity and specificityen
dc.subjectsingle photon emission computed tomographyen
dc.subjectthree-dimensional imagingen
dc.subjecttreatment indicationen
dc.subjecttwo-dimensional imagingen
dc.subjectcardiovascular systemen
dc.subjectpositron emission tomographyen
dc.subjectpositron emission tomography-computed tomographyen
dc.subjectreproducibilityen
dc.subjectCardiovascular Systemen
dc.subjectHumansen
dc.subjectMyocardial Perfusion Imagingen
dc.subjectPositron Emission Tomography Computed Tomographyen
dc.subjectPositron-Emission Tomographyen
dc.subjectRadioisotopesen
dc.subjectReproducibility of Resultsen
dc.subjectSpringer Science and Business Media Deutschland GmbHen
dc.titleEANM procedural guidelines for PET/CT quantitative myocardial perfusion imagingen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής